Alpine Immune Sciences, Inc. Free Cash Flow 2013-2024 | ALPN
Alpine Immune Sciences, Inc. free cash flow from 2013 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Alpine Immune Sciences, Inc. Annual Free Cash Flow |
| 2023 |
-79.50 |
| 2022 |
-44.17 |
| 2021 |
-15.37 |
| 2020 |
29.28 |
| 2019 |
-36.17 |
| 2018 |
-28.91 |
| 2017 |
-17.16 |
| 2016 |
-4.58 |
| 2015 |
4.81 |
| 2014 |
-14.45 |
| 2013 |
-14.42 |
| 2012 |
-9.55 |
| 2011 |
344.55 |
| 2010 |
316.52 |
| 2009 |
52.70 |
| Alpine Immune Sciences, Inc. Quarterly Free Cash Flow |
| 2024-03-31 |
-27.71 |
| 2023-12-31 |
-79.50 |
| 2023-09-30 |
-60.41 |
| 2023-06-30 |
-44.62 |
| 2023-03-31 |
-26.25 |
| 2022-12-31 |
-44.17 |
| 2022-09-30 |
-27.26 |
| 2022-06-30 |
-10.86 |
| 2022-03-31 |
5.42 |
| 2021-12-31 |
-15.37 |
| 2021-09-30 |
-0.59 |
| 2021-06-30 |
-30.72 |
| 2021-03-31 |
-16.01 |
| 2020-12-31 |
29.28 |
| 2020-09-30 |
39.12 |
| 2020-06-30 |
44.57 |
| 2020-03-31 |
-9.75 |
| 2019-12-31 |
-36.17 |
| 2019-09-30 |
-30.01 |
| 2019-06-30 |
-19.30 |
| 2019-03-31 |
-11.34 |
| 2018-12-31 |
-28.91 |
| 2018-09-30 |
-19.50 |
| 2018-06-30 |
-11.92 |
| 2018-03-31 |
-4.55 |
| 2017-12-31 |
-17.16 |
| 2017-09-30 |
-11.24 |
| 2017-06-30 |
-6.27 |
| 2017-03-31 |
-2.27 |
| 2016-12-31 |
-4.58 |
| 2016-09-30 |
-2.49 |
| 2016-06-30 |
-13.63 |
| 2016-03-31 |
-7.04 |
| 2015-12-31 |
4.81 |
| 2015-09-30 |
-13.95 |
| 2015-06-30 |
-8.17 |
| 2015-03-31 |
-4.95 |
| 2014-12-31 |
-14.44 |
| 2014-09-30 |
-11.28 |
| 2014-06-30 |
-8.16 |
| 2014-03-31 |
-4.64 |
| 2013-12-31 |
|
| 2012-12-31 |
|
